27° Simposio de la AACC sobre el Rol de Point of Care Testing

Este evento se presenta en colaboración con la División de Pruebas Criticas y Punto de Cuidado de la AACC y la Federación Internacional de Química Clínica y Medicina de Laboratorio (IFCC).

El 27 ° Simposio Internacional de C-PoCT, que se centrará en el papel actual y futuro de las pruebas en el punto de atención en un entorno de atención médica con énfasis en el valor y la calidad de la atención.

Aprenderá cómo las pruebas en el punto de atención contribuyen al valor de la atención médica a través de un tiempo de respuesta más rápido, costos de prueba más bajos, una mejor vinculación del paciente con la atención y los resultados, y una mayor satisfacción para los pacientes y los proveedores de atención médica.

Los temas de la sesión abordarán la salud pública y la prevención de enfermedades, diagnóstico y monitoreo de enfermedades para la autogestión de pacientes críticamente enfermos, en el hogar, pruebas directas al consumidor y tecnologías nuevas / emergentes

La presentación especial de la sesión del Federation of Clinical Chemistry (IFCC) – WG GMECC será el 29 de septiembre de 2018, de 11:20– 12:45:

Monitoreo de glucosa en pacientes críticos; qué debemos saber?

Una visión general del documento de la IFCC: “¿Cómo se deben evaluar los medidores de glucosa para la atención crítica?” – haga clic aquí para acceder al informe completo.

Oradores:

• Cynthia Bowman, MD; Baystate Health, Springfield, MA – US;
• Sean Cunningham, PhD, EuSpLM; Dublin, Ireland.

Programa

Photos and Credentials of Speakers

*Program is subject to change

Wednesday, September 26, 2018

• 5:30 – 6:30 pm WELCOME RECEPTION

Thursday, September 27, 2018

• 8:30 – 8:45 am OPENING REMARKS. Leslie Donato, PhD (Committee chair); Mayo Clinic, Rochester, MN
• 8:45 – 9:20 am KEYNOTE PRESENTATION. The Value of POCT in Patient Diagnosis and Improved Clinical Outcomes. Keynote Speaker: Danielle Freedman, MB BS; Luton & Dunstable University Hospital, Luton, United Kingdom
• 9:20 – 9:30 am Q&A with Dr. Freedman

SESSION 1: POCT IN PUBLIC HEALTH AND DISEASE PREVENTION. Moderator: Nichole Korpi-Steiner, PhD; University of North Carolina Hospitals

• 9:30 – 9:35 am Moderator introduction to session
• 9:35 – 10:05 am HIV testing and Linkage to Care
  Debbie Mohammed, PhD, MS, MPH; William Paterson University, Wayne, NJ
• 10:05 – 10:10 am Q&A with Dr. Mohammed
• 10:10 – 10:35 am BREAK – NETWORKING AND VISIT EXHIBITORS
• 10:35 – 11:05 am Efficacy of Child-Parent Familial Cholesterol Screening in Primary Care
  Amy Peterson, MD; University of Wisconsin School of Medicine and Public Health
• 11:05 – 11:10 am Q&A with Speaker
• 11:10 – 11:40 am Lead Screening: Effectiveness and Analytical Considerations
  Douglas Stickle, PhD; Jefferson University Hospital, Philadelphia, PA
• 11:40 – 11:45 am Q&A with Dr. Stickle
• 11:45 – 11:55 am Point of Care Creatinine to Assist Clinical Decision Making in Suspected Sepsis in the Community.
  Dimitris Poulikakos, MD; Salford Royal NHS Foundation Trust
• 11:55 am – 12:00 pm Q&A with Dimitrios Poulikakos
• 12:15 – 1:45 pm LUNCH AND VISIT EXHIBITORS

SESSION 2: DISEASE DIAGNOSIS AND MONITORING FOR THE CRITICALLY ILL
Moderator: Brad Karon, MD, PhD; Mayo Clinic, Rochester, MN

• 1:45 – 1:50 pm Moderator introduction to session
• 1:50 – 2:20 pm The Benefits and Challenges of Point of Care Testing for Respiratory Tract Infection. Leslie Wolf, PhD; Louisville Metro Public Health and Wellness Laboratory, Louisville, KY
• 2:20 – 2:25 pm Q&A with Dr. Wolf
• 2:25 – 2:55 pm Hemostasis Testing for Liver Transplant. Antonio Leon-Justel, MD; University Hospital, Institute of Biomedicine of Seville, Spain
• 2:55 – 3:00 pm Q&A with Dr. Leon-Justel
• 3:00 – 3:25 pm BREAK – NETWORKING AND VISIT EXHIBITORS
• 3:25 – 3:55 pm Update on biomarkers for acute kidney injury. Chirag Parikh, MD, PhD; Johns Hopkins University Medical Institutions, Baltimore, MD
• 3:55 – 4:00 pm Q&A with Dr. Parikh
• 4:00 – 4:10 pm Clinical Impact of an Autocorrecting Blood Glucose Monitoring System in the Severely Burned Adult Population: A Pre- and Post-Implementation Comparison Study. Nam Tran, MS, MAS, PhD; University of California, Davis, Davis, CA
• 4:10 – 4:15 pm Q&A with Dr. Tran
• 4:15 – 4:25 pm Implementation and Ongoing Support of POCT in the World’s Only Stroke Ambulance for Rural Stroke Care. Anna Füezéry, PhD; Royal Alexandra Hospital, Edmonton, Alberta, Canada
• 4:25 – 4:30 pm Q&A with Dr. Füezéry
• 4:30 – 5:30 pm RECEPTION WITH POSTER VIEWING AND VISIT EXHIBITORS

Friday, September 28, 2018

8:30 – 9:30 am CORPORATE SUPPORTER PRESENTATIONS (Industry Viewpoints)

SESSION 3: POCT IN AT-HOME PATIENT SELF-MANAGEMENT FOR ACUTE AND CHRONIC DISEASES. Moderator: Rob Nerenz, PhD; Dartmouth-Hitchcock Medical Center, Hanover, NH

• 9:30 – 9:35 am Moderator introduction to session
• 9:35 – 10:05 am Continuous Glucose Monitors – Improved Outcomes, Challenges for Laboratorians. Timothy Bailey, MD; Advanced Metabolic Care and Research Institute, University of California, San Diego, CA
• 10:05 – 10:10 am Q&A with Dr. Bailey
• 10:10 – 10:40 am TBD
  Speaker TBD
• 10:35 – 10:45 am Q&A withTBD
• 10:45 – 11:10 am BREAK – NETWORKING AND VISIT EXHIBITORS
• 11:10 – 11:40 am Monitoring Creatinine Following Renal Transplant. Celine van Lint, MSc; Leiden University Medical Center, Netherlands
• 11:40 – 11:45 am Q&A with Dr. van Lint
• 11:45 – 1:30 pm LUNCH AND VISIT EXHIBITORS

SESSION 4: POCT AND DIRECT TO CONSUMER TESTING. Moderator: T. Scott Isbell, PhD; St. Louis University School of Medicine, MO

• 1:30 – 1:35 pm Moderator introduction to session
• 1:35 – 1:55 pm Digital Health and the Engaged Patient. David Grenache, PhD; TriCore Reference Laboratories, NM
• 1:55 – 2:15 pm Legal Perspectives on Direct to Consumer Testing. Timothy Allen, MD, JD; University of Mississippi, Jackson, MS
• 2:15 – 2:35 pm Ethical Perspectives on Direct to Consumer Testing. Anita Ho, PhD, MPH; The University of British Columbia, Vancouver, Canada
• 2:35 – 3:05 pm Panel Discussion and Q&A with Session 4 speakers
• 3:05 – 3:35 pm NETWORKING AND VISIT EXHIBITORS
• 5:30 – 7:30 pm AWARDS RECEPTION at the National Press Club

Saturday, September 29, 2018

SESSION 5: NEW AND EMERGING POCT TECHNOLOGIES. Moderator: Brenda Suh-Lailam, PhD; Lurie Children’s Hospital, Chicago, IL

• 8:30 – 8:35 am Moderator introduction to session
• 8:35 – 9:05 am Ambient Ionization Mass Spectrometry for Point-of-Care Diagnostics. Graham Cooks, PhD; Purdue University, West Lafayette, IN
• 9:05 – 9:15 am Q&A with Dr. Cooks
• 9:15 – 9:45 am Genetic Testing Made Possible with a Smartphone
  Syed Hashsham, PhD; Michigan State University, Lansing, MI
• 9:45 – 9:55 am Q&A with Dr. Hashsham
• 9:55 – 10:15 am BREAK – NETWORKING and VISIT EXHIBITORS
• 10:15 – 10:45 am Sweat Analysis using Microfluidics. John Rogers, PhD; Northwestern University School of Engineering, Chicago, IL
• 10:45 – 10:55 am Q&A with Dr. Rogers
• 10:55 – 11:05 am Reducing Hospital Length of Stay and Readmission Rates in Surgical Inpatients with Diabetes Mellitus Through Improved Glycaemic Control Using an Automated Glucose System.
  Irene Kopp, NP/CDE; Nepean Diabetes Service, Penrith NSW, Australia
• 11:05 – 11:10 am Q&A with Irene Kopp
• 11:10 – 11:20 am CLOSING REMARKS. Leslie Donato, PhD (Committee chair); Mayo Clinic, Rochester, MN
• 11:20 – 12:45 SPECIAL PRESENTATION FROM THE INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY (IFCC) Glucose monitoring in critically ill patients; what do we need to know? An overview of the IFCC report: “How Should Glucose Meters be Evaluated for Critical Care?” Cynthia Bowman, MD; Baystate Health, Springfield, MA. Sean Cunningham, PhD, EuSpLM; Dublin, Ireland

Informes e inscripción

• aacc.org/the-role-of-point-of-care-testing-in-a-value-based-healthcare-landscape—27th-aacc-international